Endoscopic sleeve gastroplasty ready for implementation in clinic

WASHINGTON — Endoscopic sleeve gastroplasty – or ESG – successfully treated obesity in a new study showing its efficacy, safety and reproducibility outside the centers that launched the procedure years ago, according to research presented during Digestive Disease Week 2018.
“This international multicenter study demonstrates consistent efficacy and safety of ESG as a treatment for obesity across our study centers. Thus, we believe ESG is a safe and effective endoscopic bariatric procedure with generalizability and reproducibility,” Vivek Kumbhari, MBChB, assistant
Back to top button